HOT NEWS
Novartis
NovartisNovartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Novartis drug Signifor® recommended by CHMP for EU approval 898
2 Novartis Foundation symposium looks at impact of Information and Communication Technology 3462
3 Novartis gains European Commission approval for Rasitrio® 2305
4 Novartis associates participate in first company-wide health and well-being initiative 3421
5 Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors 3567
6 Novartis drug Afinitor® recommended by CHMP 4244
7 Novartis delivers strong financial results and four major approvals 4386
8 Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer 4932
9 Novartis drug Votubia® recommended by CHMP for approval in the EU 5154
10 Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia 5301
11 Novartis gains European Commission approval for Lucentis® 5254
12 Novartis welcomes endorsement of Pandemic Influenza Preparedness Framework at World Health Assembly 4418
13 Novartis receives EU approval for Rasilamlo® 5026
14 Novartis makes strong start for the year 3863
15 Novartis receives European Commission approval for Gilenya® 5874
16 Novartis gains positive CHMP opinion for Rasilamlo(TM) 4513
17 Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET 4052
18 Innovation drives Novartis to double-digit growth for 2010 3638
19 Sandoz announces phase II clinical trial for biosimilar version of rituximab 3994
20 Novartis submits Bexsero® for regulatory review in Europe 4373
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3
Bookmark and Share